Study of Cisplatin/Vinorelbine +/- Cetuximab as First-Line Treatment of Advanced Non Small Cell Lung Cancer(FLEX)

This study has been completed.
Information provided by EMD Pharmaceuticals

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Non Small Cell Lung Cancer
2		Additional conditions recognized in this trial
			Carcinoma, Non-Small-Cell Lung
			Lung Neoplasms
3		More general conditions related to this trial
			Carcinoma
			Lung Diseases
			Neoplasms
			Neoplasms by Histologic Type
			Neoplasms by Site
			Neoplasms, Glandular and Epithelial
			Respiratory Tract Diseases
			Respiratory Tract Neoplasms
			Thoracic Neoplasms
4		Interventions listed in this trial
			cetuximab + cisplatin + vinorelbine
			cisplatin + vinorelbine
5		Additional drug interventions recognized in this trial
			Cetuximab
			Cisplatin
			Vinorelbine
6		More general drug interventions related to this trial
			Antineoplastic Agents
			Antineoplastic Agents, Phytogenic
			Pharmacologic Actions
			Physiological Effects of Drugs
			Radiation-Sensitizing Agents
			Therapeutic Uses
7		Sponsors listed in this trial
			Merck KGaA